ArticleBritish journal of cancer2017

Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer.

A Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.